The resultant colonies were imaged and quantitatively assessed using the CellCounter software (Nghia, Ho), version 0.2.1 (https://nghiaho.com/), and enabling precise evaluation of the cytotoxic capacity of the T cells against the cancer cell lines....
Interestingly, Vonghia et al., 2019 [145] mentioned that the compound tipelukast, also known as MN-001, designed as a leukotriene receptor antagonist, orally bioavailable, being anti-fibrotic and anti-inflammatory in pre-clinical models, interestingly, inhibits PDE3 and PDE4. However, a lack ...